Provided by Tiger Fintech (Singapore) Pte. Ltd.

CF Industries Holdings Inc

68.47
-3.5700-4.96%
Post-market: 67.00-1.4700-2.15%19:38 EDT
Volume:4.91M
Turnover:341.82M
Market Cap:11.61B
PE:10.16
High:73.92
Open:73.89
Low:67.34
Close:72.04
Loading ...

CF Industries Is Maintained at Equal-Weight by Barclays

Dow Jones
·
05 Mar

Barclays Adjusts Price Target on CF Industries to $95 From $100, Keeps Equalweight Rating

MT Newswires Live
·
05 Mar

5 Top Stocks to Buy in March

Motley Fool
·
04 Mar

Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market

TIPRANKS
·
04 Mar

CF Industries Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Mar

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Monkey
·
04 Mar

CF Industries Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Mar

4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

GlobeNewswire
·
01 Mar

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
28 Feb

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Business Wire
·
28 Feb

Press Release: BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million

Dow Jones
·
26 Feb

CF Industries Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
26 Feb

CF Industries Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
26 Feb

CF Industries price target lowered to $90 from $100 at RBC Capital

TIPRANKS
·
25 Feb

U.S. RESEARCH ROUNDUP-Domino's Pizza, Owens Corning, Ventas

Reuters
·
25 Feb

CF Industries Holdings Inc : RBC Cuts Target Price to $90 From $100

THOMSON REUTERS
·
25 Feb

CF Industries Holdings, Inc. to Participate in Upcoming Investor Conference

Business Wire
·
25 Feb

BofA upgrades CF Industries on improved nitrogen market, risk/reward

Investing.com
·
25 Feb

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025

Business Wire
·
25 Feb

CF Industries Shares Reasonably Priced on Post-Earnings Sell-Off, Nitrogen Price Rally, BofA Says

MT Newswires Live
·
25 Feb